[(2R,3S,4R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-(trifluoromethyl)phosphinic acid

C11H13F3N5O7P — CID 135976349

IUPAC[(2R,3S,4R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-(trifluoromethyl)phosphinic acid
SMILESNc1nc2c(ncn2C2O[C@H](COP(=O)(O)C(F)(F)F)[C@@H](O)[C@H]2O)c(=O)[nH]1
InChIInChI=1S/C11H13F3N5O7P/c12-11(13,14)27(23,24)25-1-3-5(20)6(21)9(26-3)19-2-16-4-7(19)17-10(15)18-8(4)22/h2-3,5-6,9,20-21H,1H2,(H,23,24)(H3,15,17,18,22)/t3-,5-,6-,9?/m1/s1
InChIKeyCPGRJVITWRYEPR-LZGMGDPASA-N
MW415.22 g/mol
LogP-0.96
Rot. Bonds4

About [(2R,3S,4R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-(trifluoromethyl)phosphinic acid

[(2R,3S,4R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-(trifluoromethyl)phosphinic acid (PubChem CID 135976349) has the molecular formula C11H13F3N5O7P and a molecular weight of 415.22 g/mol. Its IUPAC name is [(2R,3S,4R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-(trifluoromethyl)phosphinic acid.

Molecular Properties

Compound Name[(2R,3S,4R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-(trifluoromethyl)phosphinic acid
PubChem CID135976349
Molecular FormulaC11H13F3N5O7P
Molecular Weight415.22 g/mol
Exact Mass415.05
IUPAC Name[(2R,3S,4R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-(trifluoromethyl)phosphinic acid
SMILESNc1nc2c(ncn2C2O[C@H](COP(=O)(O)C(F)(F)F)[C@@H](O)[C@H]2O)c(=O)[nH]1
InChIInChI=1S/C11H13F3N5O7P/c12-11(13,14)27(23,24)25-1-3-5(20)6(21)9(26-3)19-2-16-4-7(19)17-10(15)18-8(4)22/h2-3,5-6,9,20-21H,1H2,(H,23,24)(H3,15,17,18,22)/t3-,5-,6-,9?/m1/s1
InChIKeyCPGRJVITWRYEPR-LZGMGDPASA-N
XLogP-0.96
TPSA185.81 Ų
H-Bond Donors5
H-Bond Acceptors10
Rotatable Bonds4
Heavy Atoms27
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500415.22
LogP ≤ 5-0.96
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze [(2R,3S,4R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-(trifluoromethyl)phosphinic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(2R,3S,4R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-(trifluoromethyl)phosphinic acid?
The IUPAC name of [(2R,3S,4R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-(trifluoromethyl)phosphinic acid (CID 135976349) is [(2R,3S,4R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-(trifluoromethyl)phosphinic acid.
What is the SMILES notation for [(2R,3S,4R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-(trifluoromethyl)phosphinic acid?
The canonical SMILES for [(2R,3S,4R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-(trifluoromethyl)phosphinic acid is Nc1nc2c(ncn2C2O[C@H](COP(=O)(O)C(F)(F)F)[C@@H](O)[C@H]2O)c(=O)[nH]1.
What is the InChIKey of [(2R,3S,4R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-(trifluoromethyl)phosphinic acid?
The InChIKey is CPGRJVITWRYEPR-LZGMGDPASA-N. The full InChI is InChI=1S/C11H13F3N5O7P/c12-11(13,14)27(23,24)25-1-3-5(20)6(21)9(26-3)19-2-16-4-7(19)17-10(15)18-8(4)22/h2-3,5-6,9,20-21H,1H2,(H,23,24)(H3,15,17,18,22)/t3-,5-,6-,9?/m1/s1.
What are the key properties of [(2R,3S,4R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-(trifluoromethyl)phosphinic acid?
[(2R,3S,4R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-(trifluoromethyl)phosphinic acid has a molecular weight of 415.22 g/mol, XLogP of -0.96, 4 rotatable bonds, 5 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for [(2R,3S,4R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-(trifluoromethyl)phosphinic acid is sourced from PubChem (CID 135976349), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).